Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Long-term treatment with supraphysiological doses of thyroid hormone in affective disorders - effects on bone mineral density.

Ricken R, Bermpohl F, Schlattmann P, Bschor T, Adli M, Mönter N, Bauer M.

J Affect Disord. 2012 Jan;136(1-2):e89-94. doi: 10.1016/j.jad.2011.06.011. Epub 2011 Jul 14.

PMID:
21757236
2.

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.

Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C, Rasgon N, Sasse J, Whybrow PC.

J Affect Disord. 2004 Dec;83(2-3):183-90.

PMID:
15555712
3.

Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.

Ongphiphadhanakul B, Puavilai G, Rajatanavin R.

J Med Assoc Thai. 1996 Sep;79(9):563-7.

PMID:
8996984
4.

Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation.

Gyulai L, Bauer M, Garcia-Espana F, Hierholzer J, Baumgartner A, Berghöfer A, Whybrow PC.

J Affect Disord. 2001 Oct;66(2-3):185-91.

PMID:
11578671
5.

Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.

Chen CH, Chen JF, Yang BY, Liu RT, Tung SC, Chien WY, Lu YC, Kuo MC, Hsieh CJ, Wang PW.

J Formos Med Assoc. 2004 Jun;103(6):442-7.

PMID:
15278189
6.

Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.

Florkowski CM, Brownlie BE, Elliot JR, Ayling EM, Turner JG.

N Z Med J. 1993 Oct 27;106(966):443-4.

PMID:
8233173
7.
8.

Effect of replacement doses of thyroxine on bone mineral density.

Hanna FW, Pettit RJ, Ammari F, Evans WD, Sandeman D, Lazarus JH.

Clin Endocrinol (Oxf). 1998 Feb;48(2):229-34.

PMID:
9579237
9.

Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.

Ghannam NN, Hammami MM, Bakheet SM, Khan BA.

Calcif Tissue Int. 1999 Jul;65(1):23-8.

PMID:
10369729
10.

Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.

Jódar E, Begoña López M, García L, Rigopoulou D, Martínez G, Hawkins F.

Osteoporos Int. 1998;8(4):311-6.

PMID:
10024900
11.

Effects of levothyroxine suppressive therapy on bone mineral density in premenopausal women.

Larijani B, Gharibdoost F, Pajouhi M, Sadjadi A, Aghakhani S, Eshraghian R, Akrami SM, Maalouf G.

J Clin Pharm Ther. 2004 Feb;29(1):1-5.

PMID:
14748891
12.
13.

The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.

Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2001 Apr;54(4):525-32.

PMID:
11318789
14.

Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.

Garton M, Reid I, Loveridge N, Robins S, Murchison L, Beckett G, Reid D.

Clin Endocrinol (Oxf). 1994 Dec;41(6):747-55.

PMID:
7889610
15.

The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis.

Hämäläinen H, Kautiainen H, Kaarela K, Kotaniemi A.

Clin Exp Rheumatol. 2005 Mar-Apr;23(2):193-8.

PMID:
15895889
16.

[Bone mineral density in patients on long-term therapy with levothyroxine].

Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B.

Lijec Vjesn. 1998 May;120(5):103-5. Croatian.

PMID:
9748785
17.

Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.

Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, Sanmartí A.

Endocr Relat Cancer. 2005 Dec;12(4):973-81.

18.

Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen.

Schneider DL, Barrett-Connor EL, Morton DJ.

JAMA. 1994 Apr 27;271(16):1245-9.

PMID:
7848399
19.

Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status.

Serraclara A, Jódar E, Sarabia F, Hawkins F.

J Clin Densitom. 2001 Fall;4(3):249-55.

PMID:
11740067
20.

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.

Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M.

Clin Endocrinol (Oxf). 1994 Oct;41(4):425-32.

PMID:
7955453

Supplemental Content

Support Center